Creo Medical Group PLC (AIM:CREO)
London · Delayed Price · Currency is GBP · Price in GBX 13.00
+0.60 (4.84%)
Aug 17, 2026, 4:35 PM GMT
Creo Medical Group Revenue
Creo Medical Group had revenue of 2.20M GBP in the half year ending June 30, 2025, a decrease of -85.99%. This brings the company's revenue in the last twelve months to 4.60M, down -72.46% year-over-year. In the year 2024, Creo Medical Group had annual revenue of 4.00M.
Revenue (ttm)
4.60M
Revenue Growth
-72.46%
P/S Ratio
9.28
Revenue / Employee
57.69K
Employees
104
Market Cap
55.69M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 4.00M | - | - |
| Dec 31, 2023 | 4.00M | -23.20M | -85.29% |
| Dec 31, 2022 | 27.20M | 2.04M | 8.10% |
| Dec 31, 2021 | 25.16M | 15.73M | 166.85% |
| Dec 31, 2020 | 9.43M | 9.42M | 69,884.41% |
| Dec 31, 2019 | 13.47K | - | - |
| Jun 30, 2018 | - | - | - |
| Jun 30, 2017 | - | - | - |
| Feb 29, 2016 | - | - | - |
| Feb 28, 2015 | - | - | - |
| Feb 28, 2014 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 46.25B |
| GSK plc | 33.20B |
| Haleon | 11.15B |
| Smith & Nephew | 4.77B |
| ECO Animal Health Group | 87.53M |
| Kooth | 63.29M |
| hVIVO | 49.66M |
| Shield Therapeutics | 36.93M |